Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases;Analiza ekspresji czasteczek Fas, FasL oraz kaspazy 8 w tkance gruczolu tarczowego u mlodych pacjentów z chorobami immunologicznymi i nieimmunologicznymi gruczolu tarczowego

Endokrynologia Polska

Volumn 58, Issue 4, 2007, Pages 303-313

  Bossowski, Artur ^a   Czarnocka, Barbara ^b   Stasiak Barmuta, Anna ^a   Bardadin, Krzysztof ^b   Urban, Miroslawa ^a   Dadan, Jacek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Apoptosis; Caspase 8; Fas; FasL; Graves' disease

Indexed keywords

CASPASE 8; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CHILD; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NODULAR GOITER; PATHOPHYSIOLOGY; THYROID DISEASE; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CASPASE 8; CHILD; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GOITER, NODULAR; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; THYROID DISEASES;

EID: 38449109390     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Salamaco C, Bagnasco M, Pesce G i wsp. Regulation of apoptosis in endocrine autoimmunity. Ann NY Acad Sci 2002; 966: 496-501.
2. Vaux D, Flavell RA. Apoptosis genes and autoimmunity. Curr Opin Immunol 2000; 12: 719-724.
3. Andrikoula M, Tsatsoulis A. The role of Fas-mediated apoptosis in thyroid disease. Eur J Endocrinol 2001; 144: 561-568.
4. Kroemer G, Zamzami N, Susin SA. Mitochondria control of apoptosis. Immunol Today 1997; 18: 44-51.
5. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
6. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends in Cell Biology 2000; 10: 369-377.
7. Tsatsoulis A. The role of apoptosis in thyroid disease. Minerva Med 2002; 93: 169-180.
8. Mitsiades N, Poulaki V, Mitsiades CS i wsp. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol Metab 2001; 12 (9): 384-390.
9. Giordano C, Richiusa P, Bagnasco M i wsp. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid 2001; 11 (3): 245-247.
10. Wei Y, Chen K, Sharp GC i wsp. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatosus experimental autoimmune thyroiditis. J Immunol 2001; 167: 6678-6686.
11. Hiromatsu Y, Hoshino T, Yagita H i wsp. Functional Fas ligand expression in thyrocytes from patients with Graves' disease. J Clin Endocrinol Metab 1999; 84: 2896-2902.
12. Kawakami A, Eguchi K. Involvement of apoptotic cell death in autoimmune diseases. Med. Electron Microsc 2002; 35: 1-8.
13. Weetman AP, McGregor AM. Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev 1994; 15: 788-830.
14. Constagliola S, Many MC, Denef JF i wsp. Genetic immunization of out bred mice with thyrotropin receptor cDNA provides a model of Graves'disease. J Clin Incest 2000; 105: 803-811.
15. Pujol-Borrel R, Todd I, Londei M i wsp. New ideas in thyroid autoimmunity. Horm Res 1987; 26: 118-124.
16. Baker JR Jr. The nature of apoptosis in the thyroid and the role it may play in autoimmune thyroid disease. Thyroid 2001; 11: 245-247.
17. Stassi G, Zeuner A, Di Liberto D i wsp. Fas/FasL in Hashimoto's thyroiditis. J Clin Immunol 2001; 21: 19-23.
18. Giordano C, Stassi G, De Maria R i wsp. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960-963.
19. Stassi G, Todaro M, Bucchieri F i wsp. Fas/Fas ligand-driven T cell apoptosis as a conseqence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J Immunol 1999; 162: 263-267.
20. Heter M, Aust G, Ode-Hakim S i wsp. Different cytokinez mRNA profiles in Graves'disease, Hashimoto's thyroiditis and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996; 6: 97-106.
21. Stassi G, Zeuner A, Di Liberto D i wsp. Fas/FasL in Hashimoto's thyroiditis. J Clin Immunol 2001; 21: 19-23.
22. Stassi G, De Maria R. Autoimmune thyroid disease: New models of cell death in autoimmunity. Nat Rev Immunol 2002; 2: 195-204.
23. Kawakami A, Eguchi N, Matsuoka N i wsp. Modulation of Fasmediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Clin Exp Immunol 1997; 110: 434-439.
24. Mihara S, Suzuki N, Wakisaka S i wsp. Effects of thyroid hormones on apoptotic cell death of human lymphocytes. J Clin Endocrinol Metab 1999; 84: 1378-1385.
25. De Maria R, Testi R. Fas-FasL interactions: a common pathogenetic mechanizm in organ-specific autoimmunity. Immunol Today 1998; 19: 121-125.
26. Fisher GN, Rosenberg FJ, Strans SF i wsp. Dominant interfering Fas gene mutations impair apoptosis in a human lymphoproliterative syndrome. Cell 1995; 81: 935-946.
27. Rieux-Loucat R, Le Deist F, Hivroz C i wsp. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347-1349.
28. Bona G, Defranco S, Chiocchetti A i wsp. Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diesases. Clin Exp Immunol 2003; 133: 430-437.